Please assess the completion status of the following clinical trial:

Trial Title: Use of the Leva Incontinence System in Treating Bladder Incontinence.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria~* Subjects must be female.~* Subjects must be capable of giving informed consent.~* Subjects should be at least 18 years of age and less than 89 years of age~* Subjects must have a diagnosis of or symptoms of predominant mild to moderate urinary incontinence based on the results of the completed urinary incontinence surveys.~Exclusion Criteria:~* Absence of a vagina.~* Positive drug or alcohol test at the screening visit.~* Post-menopausal defined as absence of a period for over 12 months.~* Pregnancy or being less than 12 months post-partum.~* Greater than three vaginal deliveries or prior operative delivery (e.g. use of vacuum, forceps or abdominal pressure).~* Symptoms of stage II or greater pelvic organ prolapse.~* BMI \>31 kg/m2.~* Diagnosis of any neurological disorder.~* Prior lower back or pelvic surgery, including prior surgery for stress urinary incontinence (SUI).~* Prior pelvic radiation.~* Current or recurrent vaginal infections (\>three per year).~* Painful bladder syndrome, active or chronic pelvic pain.~* Concurrent Pelvic Floor Muscle Exercises (PFME) under a supervised therapeutic plan of care.~* Previous supervised pelvic floor muscles rehabilitation in the past 12 months for the treatment for urinary incontinence or any other pelvic floor disorder.~* Currently taking medication to treat incontinence.~* Impaired cognitive function.~* Unable to tolerate use of the leva device.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Leva Arm (Type: EXPERIMENTAL): Subjects will use the leva device twice daily to perform pelvic floor muscle exercises

Based on this trial design, predict the completion outcome and termination type (if applicable).